Igboeli P, Kapp D S, Lawrence R, Schwartz P E
Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):153-9. doi: 10.1016/0360-3016(83)90092-5.
Eighty-nine patients with previously untreated invasive carcinoma of the cervical stump were seen at Yale-New Haven Hospital from 1953 through 1977. This represented 9.4% of the carcinomas of the cervix seen during this time period. Eighty-five of the 89 patients (95.5%) had "true" cancers of the cervical stump diagnosed 2 years or more after subtotal hysterectomy, while 4 of the 89 patients (4.5%) had "coincident" cancers diagnosed within 2 years of the subtotal hysterectomy. All cervical cancers were staged by the F.I.G.O. classification. Patient characteristics, methods of management, failure sites and survival of patients with carcinoma of the cervical stump were compared to those patients with carcinoma in the intact uterus. Patients with cervical stump cancers were treated in a similar manner to those with carcinomas of the intact uterus, using a combination of external beam irradiation and intracavitary radium. The stump cancer patients had a similar stage distribution to the patients with cancers of the intact uterus but, on the average, they were older and received less irradiation. The patterns of failure were similar on a stage for stage basis, but the survival and disease-free survival for stump cancer patients were superior to those of the patients with carcinoma of the intact uterus. The 5-year disease-free survival rates according to stage for the patients with carcinoma of the cervical stump were: 83.8% for Stage I, 77.6% for Stage II, 51.0% for Stage III, and 37.1% for Stage IV; compared with 84.2%, 60.9%, 30.1% and 18.3% for the intact uterus in the same stages.
1953年至1977年期间,耶鲁-纽黑文医院共收治了89例既往未经治疗的宫颈残端浸润癌患者。这占该时间段内所见宫颈癌病例的9.4%。89例患者中有85例(95.5%)在次全子宫切除术后2年或更长时间被诊断为宫颈残端“真性”癌,而89例患者中有4例(4.5%)在次全子宫切除术后2年内被诊断为“同时性”癌。所有宫颈癌均按照国际妇产科联盟(F.I.G.O.)分类法进行分期。将宫颈残端癌患者的特征、治疗方法、复发部位及生存率与完整子宫癌患者进行了比较。宫颈残端癌患者的治疗方式与完整子宫癌患者相似,采用外照射和腔内镭疗相结合的方法。宫颈残端癌患者的分期分布与完整子宫癌患者相似,但平均而言,他们年龄更大,接受的放疗剂量更少。在分期基础上,复发模式相似,但宫颈残端癌患者的生存率和无病生存率优于完整子宫癌患者。宫颈残端癌患者按分期的5年无病生存率分别为:I期83.8%,II期77.�%,III期51.0%,IV期37.1%;而完整子宫癌患者在相同分期的相应生存率分别为84.2%、60.9%、30.1%和18.3%。